The rapid antidepressant and anxiolytic-like effects of YY-21 involve enhancement of excitatory synaptic transmission via activation of mTOR signaling in the mPFC | |
Guo, Fei1; Zhang, Bing1,2; Fu, Zhiwen1,2; Ma, Yuqin1,2; Gao, Yu1,2; Shen, Fuyi1,2; Huang, Chenggang1; Li, Yang1 | |
刊名 | EUROPEAN NEUROPSYCHOPHARMACOLOGY |
2016-07 | |
卷号 | 26期号:7页码:1087-1098 |
关键词 | YY-21 mTOR Synaptic transmission Synaptic proteins |
ISSN号 | 0924-977X |
DOI | 10.1016/j.euroneuro.2016.05.006 |
文献子类 | Article |
英文摘要 | Although antidepressants have been widely prescribed to treat patients with major depressive disease (MDD), there is little disagreement over the need for improved antidepressant therapeutics as the typical treatments have a slow therapeutic onset and moderate efficacy. In the present study, we assessed a novel compound, YY-21, from timosaponin B-III derived from sarsasapogenin of Anemarrhenae Rhizoma. From the initial results, we found that YY-21 obviously increased presynaptic glutamate release and enhanced long-term synaptic activity within 10 min as determined by excitatory postsynaptic current (EPSC) and field excitatory postsynaptic potential (fEPSP) in medial prefrontal cortex (mPFC) slices, respectively. YY-21 demonstrated anxiolytic-like effects following acute administration in naive animals and reversed the depressive-like and anxiety phenotypes induced by chronic unpredictable mild stress (CMS) with a relatively fast therapeutic onset. Furthermore, analysis of intracellular signaling pathways showed that YY-21 normalized the CMS-induced low protein levels of GluN2B, p-mTOR, synaptic-related proteins, such as BDNF, PSD-95 and GluA1. Pre-application of the mTOR-selective inhibitor rapamycin blocked YY-21-induced long-term synaptic enhancement. These findings suggest that the activation of BDNF-dependent mTOR signaling, which produces a rapid increase in the postsynaptic protein PSD-95 and GluA1 and further triggers the long-term enhancement of synaptic neurotransmission, may be the mechanism underlying the rapid antidepressant and anxiolytic effects induced by YY-21. (C) 2016 Elsevier B.V. and ECNP. All rights reserved. |
资助项目 | National Natural Science Foundation[31200771] ; National Natural Science Foundation[81030065] ; National Natural Science Foundation[81274055] ; National Natural Science Foundation[3137106601] ; National Natural Science Foundation[3117101101] ; Ministry of Science and Technology[2013CB91060101] ; National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program'[2012ZX09301-001-06] ; National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program'[2014ZX09102001-005] |
WOS关键词 | UNIPOLAR MOOD DISORDERS ; STAR-ASTERISK-D ; ANXIETY DISORDERS ; DEPRESSION ; STRESS ; BDNF ; CORTEX ; COMORBIDITY ; ANTAGONISTS ; MECHANISMS |
WOS研究方向 | Neurosciences & Neurology ; Pharmacology & Pharmacy ; Psychiatry |
语种 | 英语 |
出版者 | ELSEVIER SCIENCE BV |
WOS记录号 | WOS:000383340100001 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/275965] |
专题 | 药理学第二研究室 上海中药现代化研究中心 |
通讯作者 | Guo, Fei; Huang, Chenggang; Li, Yang |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Shanghai 201203, Peoples R China; 2.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China |
推荐引用方式 GB/T 7714 | Guo, Fei,Zhang, Bing,Fu, Zhiwen,et al. The rapid antidepressant and anxiolytic-like effects of YY-21 involve enhancement of excitatory synaptic transmission via activation of mTOR signaling in the mPFC[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY,2016,26(7):1087-1098. |
APA | Guo, Fei.,Zhang, Bing.,Fu, Zhiwen.,Ma, Yuqin.,Gao, Yu.,...&Li, Yang.(2016).The rapid antidepressant and anxiolytic-like effects of YY-21 involve enhancement of excitatory synaptic transmission via activation of mTOR signaling in the mPFC.EUROPEAN NEUROPSYCHOPHARMACOLOGY,26(7),1087-1098. |
MLA | Guo, Fei,et al."The rapid antidepressant and anxiolytic-like effects of YY-21 involve enhancement of excitatory synaptic transmission via activation of mTOR signaling in the mPFC".EUROPEAN NEUROPSYCHOPHARMACOLOGY 26.7(2016):1087-1098. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论